Biotechnology News and Research

RSS

Russian scientists create humanized mice to test drugs and vaccines for COVID-19

Following the recent Coronavirus outbreak, almost three million people have been infected worldwide, whereas the death toll has already passed the 200,000 mark, according to official reports.

5 May 2020

Discovery heralds a new strategy in the hunt for antibiotics

Scientists have identified a key process in the way bacteria protect themselves from attack - and it heralds a new strategy in the hunt for antibiotics.

3 May 2020

Racial inequalities in liver cancer mortality increased after introduction of hepatitis C drugs

In the United States, hepatocellular or liver cancer deaths have doubled since 1979. Hepatitis C virus is the leading cause of liver cancer.

30 Apr 2020

Medical staff fighting COVID-19 experience serious skin injury related to PPE use

A new study of medical staff treating COVID-19-infected patients found 42.8% experienced serious skin injury related to the use of personal protective equipment, including masks, goggles, face shields, and protective gowns.

30 Apr 2020

UK-based biotechnology firm discovers potential treatments for Covid-19

A UK-based biotechnology firm has announced the discovery of two separate novel treatments for Covid-19 patients before they are put on ventilators. They are now urgently seeking funding of £4m to accelerate safety studies and clinical trials.

30 Apr 2020

Antibody produced by llamas shows promise against SARS-CoV-2

The hunt for an effective treatment for COVID-19 has led one team of researchers to find an improbable ally for their work: a llama named Winter.

29 Apr 2020

Study explores the growth rate effect of gut bacteria on break down of dietary fibers

It is known that approximately 80% of human immune system functions in the gastrointestinal tract. Gut bacteria and their metabolites play a fundamental role in the interaction between gut and other organs.

29 Apr 2020

Epivax and Entos Pharmaceuticals to develop DNA-based vaccine for COVID-19

Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.

28 Apr 2020

Ayurveda and yoga could provide an effective, affordable means for COVID-19 prevention

Experts in Indian traditional medicine, including the chair of the Government of India's committee charged to lead that nation's efforts on the potential uses of traditional medicine relative to COVID-19, describe how the approach of Ayurveda and yoga may help strengthen host immunity and provide an effective, accessible, and affordable means of prophylaxis of COVID-19 infection.

28 Apr 2020

Mobile telehealth system used in China to enable clinical communication during COVID-19

A mobile telehealth system (MTS) has been used in a hospital in China where COVID-19 patients were treated in isolation wards set off from other healthcare providers.

28 Apr 2020

New DNA test will improve tracking of Salmonella food-poisoning outbreaks

Researchers report an assay to detect serotypes of Salmonella, paving the way for rapid serotyping directly from specimens.

28 Apr 2020

India's Serum Institute gears up to make millions of doses of potential COVID-19 vaccine

The Serum Institute of India plans to start manufacturing Oxford University's COVID-19 vaccine in 3 weeks to get a head start on production, the company announced. This comes even as experts warn that any successful vaccine will take two or more years to come on the market.

28 Apr 2020

Study marks a major step towards beta cell replacement therapy

The loss of insulin-secreting beta cells by autoimmune destruction leads to type 1 diabetes. Clinical islet cell transplantation has the potential to cure diabetes, but donor pancreases are rare.

28 Apr 2020

Researchers identify a new risk factor for multiple neurodegenerative diseases

Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.

28 Apr 2020

Diamond Pharma Services acquires PharmaCentral to strengthen pharmacovigilance division

Diamond Pharma Services today announced its pharmacovigilance division, Diamond PV Services, has acquired PharmaCentral.

27 Apr 2020

A new test for rapid large-scale testing of COVID-19

OU Medicine, the OU Health Sciences Center and the Oklahoma Medical Research Foundation collaborated to create a new test for COVID-19 using technology and reagents from Fluidigm Corporation, an innovative biotechnology tools provider

25 Apr 2020

Scientists are developing synthetic COVID-19 antibody to treat sick patients

A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended to block the virus from entering human lung cells, and would be another potential treatment option for COVID-19.

24 Apr 2020

Novotech: Many countries in Asia-Pacific are fast-tracking COVID-19 clinical trials

The Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates.

24 Apr 2020

Emergex partners with George Mason University for highly pathogenic RNA virus studies

Emergex Vaccines Holding Limited, a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, today announced that it has entered into an agreement with the George Mason University, based in Virginia, in the United States.

22 Apr 2020

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

Accelerating antibody discovery using picodroplet technology for single cell analysis to condense discovery times down to 1-2 days.

From Fluidic Sciences and Sphere Bio 22 Apr 2020

Biotechnology News and Research

Russian scientists create humanized mice to test drugs and vaccines for COVID-19

Discovery heralds a new strategy in the hunt for antibiotics

Racial inequalities in liver cancer mortality increased after introduction of hepatitis C drugs

Medical staff fighting COVID-19 experience serious skin injury related to PPE use

UK-based biotechnology firm discovers potential treatments for Covid-19

Antibody produced by llamas shows promise against SARS-CoV-2

Study explores the growth rate effect of gut bacteria on break down of dietary fibers

Epivax and Entos Pharmaceuticals to develop DNA-based vaccine for COVID-19

Ayurveda and yoga could provide an effective, affordable means for COVID-19 prevention

Mobile telehealth system used in China to enable clinical communication during COVID-19

New DNA test will improve tracking of Salmonella food-poisoning outbreaks

India's Serum Institute gears up to make millions of doses of potential COVID-19 vaccine

Study marks a major step towards beta cell replacement therapy

Researchers identify a new risk factor for multiple neurodegenerative diseases

Diamond Pharma Services acquires PharmaCentral to strengthen pharmacovigilance division

A new test for rapid large-scale testing of COVID-19

Scientists are developing synthetic COVID-19 antibody to treat sick patients

Novotech: Many countries in Asia-Pacific are fast-tracking COVID-19 clinical trials

Emergex partners with George Mason University for highly pathogenic RNA virus studies

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News